On behalf of the Endocrine Society’s Early-Career Special Interest Group (SIG), Milay Luis Lam, MD, shares her early-career journey from Peru to the U.S., and what she learned every step of the way. Read why it’s important for the next generation of endocrinologists – both physicians and scientists – to be aware of the varied...
Hormones may be leveraged to treat and prevent signs of aging such as wrinkles and hair graying, according to a new study published in the Endocrine Society journal Endocrine Reviews. Until now, only a limited number of hormones, mainly topical retinoids (retinol and tretinoin) and estrogen which is typically used to treat side effects of menopause,...
At Arm’s Length: A Look at a New Mealtime, Injection-Free Insulin Patch
Priyanka Majety, MD, discusses a new, FDA-approved wearable insulin-delivery patch that could potentially improve patients’ insulin adherence as well as their quality of life. Last summer, a wearable patch designed for mealtime insulin delivery (in lieu of traditional injections) received clearance from the U.S. Food and Drug Administration, extending the patch’s wear time from three...
Society for Women’s Health Research Award Honors Teresa Woodruff
The Society for Women’s Health Research (SWHR) will honor Teresa Woodruff, PhD, with a Women’s Health Visionary Award for her contributions to women’s health research in endocrinology, ovarian biology, and reproductive science during its 35th Annual Awards Gala. Woodruff is also being honored for her leadership surrounding the sex as a biological variable policy within the... Last month, The Journal of Clinical Endocrinology and Metabolism published a classic congenital adrenal hyperplasia (CAH)-focused supplement, titled “Challenges and Opportunities in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency Throughout the Lifetime.” The supplement contains eight review articles that provide a comprehensive look at the clinical, psychosocial, treatment-related and day-to-day challenges...
Donald Patrick McDonnell, PhD, has been awarded the Endocrine Society’s John D. Baxter Prize for Entrepreneurship for discovering hormone therapies for treating breast and prostate cancer, the Society announced today. The John D. Baxter Prize for Entrepreneurship was established to recognize the extraordinary achievement of bringing an idea, product, service, or process to market. This...Stay Connected with the Society’s Curated Communications Channels
We grow as professionals by staying informed on emerging research and developments in our field. As your professional home, the Society offers a variety of resources to help you keep pace with the latest trends and cutting-edge science and clinical practice. No matter what time zone you live in, no matter how you prefer to... An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves New Treatment Option For A Leading Cause of Diabetes-Related Blindness Genentech, a member of the Roche Group on February 4 announced that the U.S. Food and Drug Administration (FDA) approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of...
